Night shift health | Viagra and Alzheimer’s | COVID-19 and RSV antiviral

National Institutes of Health (NIH) sent this bulletin at 12/14/2021 04:10 PM EST

Having trouble viewing this email? View it as a Web page.

December 14, 2021 Edition

We at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines for COVID-19. You can find the latest public health information from CDC at https://www.cdc.gov/coronavirus and the latest research information from NIH at https://www.covid19.nih.gov. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.

Daytime meals may reduce health risks of night shift work

A small study found that eating only during the daytime prevented the high blood sugar linked to night shift work.

Portrait of an older man deep in thought

Viagra associated with reduced risk of Alzheimer’s disease

Findings of a new study support further investigation of sildenafil as a possible treatment for Alzheimer’s disease.

3D rendering of different types of viruses

Antiviral drug shows promise against COVID-19 and RSV

A drug called 4’-fluorouridine effectively treated both COVID-19 and respiratory syncytial virus, or RSV, in animals.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.